amfenac has been researched along with Retinal Neovascularization in 1 studies
amfenac: RN given refers to parent cpd; structure
amfenac : An oxo monocarboxylic acid that is benzophenone in which one of the phenyl groups is substituted by an amino group and a carboxymethyl group at position 2 and 3, respectively. The corresponding carboxamide, nepafenac, is a prodrug of amfenac and is used for the treatment of pain and inflammation following cataract surgery.
Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amfenac treatment failed to inhibit hypoxia-induced VEGF production." | 1.36 | The effects of nepafenac and amfenac on retinal angiogenesis. ( Bingaman, DP; Clark, ML; Penn, JS; Yang, R; Yanni, SE, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yanni, SE | 1 |
| Clark, ML | 1 |
| Yang, R | 1 |
| Bingaman, DP | 1 |
| Penn, JS | 1 |
1 other study available for amfenac and Retinal Neovascularization
| Article | Year |
|---|---|
The effects of nepafenac and amfenac on retinal angiogenesis.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Benzeneace | 2010 |